171 related articles for article (PubMed ID: 8195176)
1. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase.
Tauchi T; Feng GS; Shen R; Song HY; Donner D; Pawson T; Broxmeyer HE
J Biol Chem; 1994 May; 269(21):15381-7. PubMed ID: 8195176
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
3. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp.
Feng GS; Shen R; Heng HH; Tsui LC; Kazlauskas A; Pawson T
Oncogene; 1994 Jun; 9(6):1545-50. PubMed ID: 8183548
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
Tanaka S; Ito T; Wands JR
J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
[TBL] [Abstract][Full Text] [Related]
5. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways.
Tauchi T; Feng GS; Shen R; Hoatlin M; Bagby GC; Kabat D; Lu L; Broxmeyer HE
J Biol Chem; 1995 Mar; 270(10):5631-5. PubMed ID: 7534299
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells.
Tauchi T; Feng GS; Marshall MS; Shen R; Mantel C; Pawson T; Broxmeyer HE
J Biol Chem; 1994 Oct; 269(40):25206-11. PubMed ID: 7523381
[TBL] [Abstract][Full Text] [Related]
7. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
[TBL] [Abstract][Full Text] [Related]
8. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
9. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp.
Kuhné MR; Pawson T; Lienhard GE; Feng GS
J Biol Chem; 1993 Jun; 268(16):11479-81. PubMed ID: 8505282
[TBL] [Abstract][Full Text] [Related]
10. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases.
Feng GS; Hui CC; Pawson T
Science; 1993 Mar; 259(5101):1607-11. PubMed ID: 8096088
[TBL] [Abstract][Full Text] [Related]
11. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.
Marengère LE; Waterhouse P; Duncan GS; Mittrücker HW; Feng GS; Mak TW
Science; 1996 May; 272(5265):1170-3. PubMed ID: 8638161
[TBL] [Abstract][Full Text] [Related]
12. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
[TBL] [Abstract][Full Text] [Related]
14. Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes.
Fuhrer DK; Feng GS; Yang YC
J Biol Chem; 1995 Oct; 270(42):24826-30. PubMed ID: 7559603
[TBL] [Abstract][Full Text] [Related]
15. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
Bai RY; Jahn T; Schrem S; Munzert G; Weidner KM; Wang JY; Duyster J
Oncogene; 1998 Aug; 17(8):941-8. PubMed ID: 9747873
[TBL] [Abstract][Full Text] [Related]
16. The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells.
Ilaria RL; Van Etten RA
Blood; 1995 Nov; 86(10):3897-904. PubMed ID: 7579359
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells.
Mizuno K; Katagiri T; Hasegawa K; Ogimoto M; Yakura H
J Exp Med; 1996 Aug; 184(2):457-63. PubMed ID: 8760799
[TBL] [Abstract][Full Text] [Related]
18. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
Sha F; Gencer EB; Georgeon S; Koide A; Yasui N; Koide S; Hantschel O
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14924-9. PubMed ID: 23980151
[TBL] [Abstract][Full Text] [Related]
19. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
20. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.
Danhauser-Riedl S; Warmuth M; Druker BJ; Emmerich B; Hallek M
Cancer Res; 1996 Aug; 56(15):3589-96. PubMed ID: 8758931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
